
Association of Adenovirus with Hepatitis of Unknown Cause in Children
Implicating adenovirus for hepatitis of unknown cause in children is confounded by its absence in some cases, and from all tested hepatic tissue.
A relation between adenovirus and the recent spate of
The initial reports, from Birmingham, Alabama, of 9 children with HUC who tested positive for adenovirus between late 2021 and early 2022 heightened global vigilance for the condition and that possible etiology. That
In this UK series, 44 children were referred to one liver-transplantation center between January 1 and April 11, 2022 with acute hepatitis that was not hepatitis A through E and was without a metabolic, inherited or genetic, congenital or mechanical cause, common toxin exposure, travel history or cytomegalovirus or (in all but 2 children) Epstein-Barr virus. Among the 30 patients who underwent testing for adenovirus, however, 27 (90%) were positive.
The investigators reported that adenovirus detection was more common in blood (93%) than in respiratory samples (67%) or feces (67%).They also noted that biochemical tests during what was found to have been the prodromal phase of acute hepatitis, as well as ultrasonographic findings of thickening of the gall bladder wall with pericholecystic fluid, abdominal lymph nodes and mild hepatosplenomegaly, "are consistent with a possible viral cause."
Chayarani Kelgeri, MD, Liver Unit, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK, and lead author of the report, considered this possibility with Contagion.
"The clinical picture does lend some credence to a viral etiology, and testing so far reveals adenovirus as the most common pathogen, though other pathogens, too, have been infrequently detected," Kelgeri said.
"What is, however, not clear, is why we haven't been able to find viral particle staining in the liver tissue," Kelgeri observed. "It is also intriguing as to why young children who have been previously healthy have been affected."
Kelgeri and colleagues speculate in their report that although adenovirus infections are typically self-limiting in immunocompetent children, there may be an immunopathogenic mechanism for the hepatic injury, and they indicate that the use of glucocorticoids in conjunction with cidofovir is being explored.
In an
"This is still the situation today," Karpen observed. "Given the young age of the patients, genetic underpinnings and, in rare cases, environmental causes are sought."
In the UK series, most of the children were previously well and, in most, the hepatitis resolved. Fulminant liver failure developed, however, in 6 of the children (14%)—all of whom received a liver transplant. No child in the series died, and all, including the 6 liver transplant recipients, were discharged home.
"Fortunately, severe cases are very few and most recover spontaneously," Kelgeri said.
Kelgeri posited that there could be some interaction with the SARS-CoV-2 pandemic. "The lockdowns may have contributed to the changes in our social and ecological systems, which means that the body's response may be different even to common pathogens, especially in children who get exposed to these pathogens a little later than usual," he commented.
For health care providers and public health systems, Kelgeri emphasized the importance of conducting thorough testing, reporting, and having robust surveillance systems in place. "Metagenomics and other specialized tests are ongoing and will perhaps help us identify the cause and/or mechanism of injury," he indicated.
For parents alarmed at yet another public health risk with, as yet, an unknown cause, Kelgeri offered some reassurance along with guidance. "Fortunately severe cases are very few and most recover spontaneously. However, it would be good to be vigilant and check with a health care professional if your child has pale stools, dark urine, eyes look yellow, or is off food. It is recommended to follow general hygiene measures like hand washing, especially after bowel movements and before eating food," Kelgeri advised.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.